Jef (an unusual nickname for Jennifer) is a freelance writer and editor covering the life sciences. She earned her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses and spent the first 13 years of her career at The Scientist, where she edited features and oversaw the production of the publication’s digital and print magazines. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.
Jef Akst
Contributing writer
From this contributor
Protein networks identified in autism-linked genetic deletion
The OTUD7A gene, which may account for some traits in people missing a segment of chromosome 15, appears to interact with several known autism-linked genes.
Protein networks identified in autism-linked genetic deletion
By
Jef Akst
28 February 2023 | 6 min read
Simons Foundation clinical research head Wendy Chung to lead Boston Children’s pediatrics department
Chung, a clinical and molecular geneticist, plans to continue serving as principal investigator of two large research projects involving cohorts of people with autism and related neurodevelopmental conditions.
Simons Foundation clinical research head Wendy Chung to lead Boston Children’s pediatrics department
By
Jef Akst
14 February 2023 | 5 min read
Head motion mars most fMRI results, even after correction
A new measure shows how greatly movement influences associations between traits and brain activity, revealing abundant false positives and false negatives.
Head motion mars most fMRI results, even after correction
By
Jef Akst
30 January 2023 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read